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Photoimmunology started almost 40
years ago with the discovery of a link
between UVR and immunosuppression
during experimental photocarcinogen-
esis. Cutaneous UVR-induced tumors
appeared to be highly antigenic, as
they were rejected upon inoculation
into syngeneic mice (Kripke, 1986).
Recipients treated with immuno-
suppressive drugs did not reject the
transplanted tumors, similar to reci-
pients who had received low doses
of UVR instead of pharmacological
immunosuppression, indicating that
UVR suppresses cellular immunity.
The most effective UVR spectrum to
alter an immune response turned out
to be the mid-wave range (UVB,
290–320 nm). Thus, most of the photo-
immunologic studies were conducted
with UVB, although UVA (320–400 nm)
certainly has an effect on immune
reactions as well.
Besides the development of skin
tumors, UVR was found to inhibit
contact hypersensitivity (Toews et al.,
1980). As mice that received the contact
allergen through UVR-exposed skin
could not be resensitized against the
same antigen a few weeks later, it was
concluded that UVR induces long-term
suppression. This appeared to be antigen
specific, as no other immune responses
were altered. As UVR exposure and
sensitization affect the same skin area,
this model is also referred to as local
immunosuppression. Later studies
showed that UVR, although at higher
doses, can also affect the immune
system in a systemic manner via the
release of soluble mediators (IL-10,
tumor necrosis factor) from the skin
(Ullrich and Schmitt, 2000). Whether
the alarmin (endogenous mediators
released upon cellular injury) IL-33
contributes to UVR-induced immuno-
suppression awaits further investigation,
although the fact that neutralization
of IL-33 blocks UVR-induced immuno-
suppression is quite convincing (Byrne
et al., 2011).
THE CHANGING ROLE OF LANGERHANS
CELLS
Soon thereafter, it was shown that
the antigen-specific immunotolerance
induced by UVR is attributable to the
occurrence of T cells with suppressive
activities (Elmets et al., 1983), at
that time called ‘‘suppressor T cells’’
and these days renamed ‘‘regulatory
T cells’’ (Tregs) (Schwarz, 2008; Loser
and Beissert, 2012). The same low
doses of UVR that suppressed sensiti-
zation depleted the Langerhans cells
(LCs) from the epidermis. Initially, it
was assumed that LCs are killed by
UVR, but later it turned out that they
leave the epidermis. As in those days
LCs were regarded as the most
important antigen-presenting cells in
the skin (Romani et al., 2012), the
failure to induce sensitization through
UVR-exposed skin was associated with
depletion of LCs from the epidermis.
Nowadays, the functional role of LCs
has been redefined. It became clear
that LCs are not the primary antigen-
presenting cells in the skin, but that this
job is mostly done by dermal dendritic
cells (Merad et al., 2008). In contrast,
LCs appear to be more involved in
downregulating than inducing immune
responses, as recently demonstrated in
diphtheria toxin receptor knock-in
mice in which LCs can be depleted
via injection of diphteria toxin (Bennett
and Clausen, 2007). Similarly, it was
shown that LCs are crucially involved
in UVR-induced immunosuppression,
as inhibition of the induction of contact
hypersensitivity (CHS) and the gene-
ration of Tregs were no longer observed
upon UVR in LC-depleted mice
(Schwarz et al., 2010). This is in
accordance with the previous finding
that the appearance of UVR-damaged
LCs in the regional lymph nodes
was required for the induction of
Tregs (Schwarz et al., 2005). This im-
plied that damaged but still alive LCs
present the antigen in a nonprofes-
sional manner and thus do not induce
T-effector cells, but Tregs. However,
additional mechanisms seem to be
involved, as it was observed that
UVR-induced upregulation of CD254
(RANKL) on keratinocytes activated
RANK-stimulated LCs to induce Tregs
(Loser et al., 2006).
UVR-INDUCED TREGS
UVR-induced Tregs appear to belong
to the CD4þCD25þ subtype, express
CTLA4, and release IL-10 (Schwarz,
2008). They express the lymph node–
homing receptor CD62L, migrate into
the lymph nodes, and thus primarily
inhibit sensitization. However, when
present in the periphery, they also
suppress the elicitiation of CHS. The
pattern of tissue-homing receptors can
be altered by tissue-specific antigen-
presenting cells (Schwarz et al., 2011).
Upon contact with LCs, UVR-Tregs
downregulate CD62L and express skin-
homing receptors. These cells mediate
their effect by migrating into the
skin and inhibit the elicitation. Hence,
UVR-Tregs can suppress both the
induction and the elicitation of CHS,
provided they are at the appropriate
site.
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INVOLVEMENT OF CELLS BEYOND T CELLS
When studying T-cell subsets involved
in UVR-induced immunosuppression,
it became evident that natural killer
T (NKT) cells are involved in the sup-
pression of tumor immune responses
by UVR (Moodycliffe et al., 2000). NKT
cells that express intermediate amounts
of T-cell receptor molecules and
coexpress surface antigens normally
found on NK cells (NK1.1, DX5, and
Ly49a) may have a critical role in
regulating the growth of UVR-induced
skin cancers.
Mast cells were previously largely
ignored in photoimmunology. How-
ever, the prevalence of murine dermal
mast cells correlated directly with their
susceptibility to UVB-induced systemic
immunosuppression, as demonstrated
in mast cell–depleted (Wf/Wf) mice (Hart
et al., 1998). In addition, mast cells can
be a source for IL-10, which mediates
tolerance in UVR-induced immuno-
suppression (Alard et al., 2001). How-
ever, the role of mast cells in regulating
CHS requires further elucidation, as
depletion of mast cells by using the
diphtheria toxin receptor knock-in
method was not associated with an
enhanced CHS response, but with a
decreased CHS response (Dudeck
et al., 2011).
Another quite neglected cell deser-
ving more attention in photoimmuno-
logy is the B cell. They appear in
increased numbers in the draining
lymph nodes upon UVR (Byrne and
Halliday, 2005) and reveal an activated
phenotype (MHCII, B220, IL-10). These
cells exert suppressive activity, and
thus were suggested to be called
UVR-activated regulatory B cells.
Studies utilizing inhibitors revealed
that serotonin and platelet-activating
factor are crucially involved in the
activation of this possibly new B-cell
subtype (Matsumura et al., 2006).
MOLECULAR EVENTS IN
PHOTOIMMUNOSUPPRESSION
A major molecular event in UVR-
mediated immunosuppression is the
induction of DNA damage. Reduction
of DNA damage via exogenous DNA
repair enzymes prevented the sup-
pression of the immune system by
UVR, indicating the essential role of
DNA damage in signal transduction
(Kripke et al.,1992). Similar observa-
tions were made when injecting cyto-
kines, such as IL-12, IL-18, and IL-23,
which induce DNA repair (Schwarz
and Schwarz 2009). Recently, it was
shown that UVR-damaged keratino-
cytes release noncoding RNA, which
binds via Toll-like receptor-3 (Bernard
et al., 2012). Toll-like receptor-3 liga-
tion on keratinocytes induces the
expression of tumor necrosis factor-a
and IL-6. This pathway appears to
be relevant also for UVR-induced
immunosuppression, as TLR3 /
mice were found to be resistant to the
immunosuppressive effects of UVR in
the CHS model.
Beyond DNA, additional chromo-
phores for UVR-induced immunosup-
pression were identified. Trans-urocanic
acid (UCA) is a histidine-derived
molecule present in the stratum cor-
neum. UVR isomerizes trans-UCA to
cis-UCA (Mohammad et al., 1999).
Removal of the stratum corneum by
tape stripping prevented UVR-induced
inhibition of CHS, suggesting that a
relevant chromophore is removed
(DeFabo and Noonan, 1983). Action
spectra identified cis-UCA as the
hottest candidate. Accordingly, injec-
tion of cis-UCA inhibited CHS. How-
ever, the mechanisms involved in
UVR- and cis-UCA-mediated immuno-
suppression do not appear to be exactly
the same. For example, anti-IL-10
antibodies blocked the induction of
UVR-induced tolerance completely
but that of cis-UCA-induced tolerance
only partially (Niizeki and Streilein
1997).
PHOTOIMMUNOLOGIC FINDINGS IN
HUMANS
UVR-induced immunosuppression in
humans may represent a risk factor for
skin cancer, as the incidence of UVR-
induced suppression of CHS is signifi-
cantly higher in skin cancer patients.
A strong association of UVR-suscep-
tible and UVR-resistant phenotypes in
humans with single-nucleotide poly-
morphisms in the tumor necrosis factor
region was found, suggesting this
region to contain genes that determine
the outcome of an UVR response
(Yoshikawa et al., 1990).
Human volunteers developed toler-
ance when the hapten was initially
painted onto UVR-treated skin (Cooper
et al., 1992). UVR not only depleted
LCs but also induced CD11bþ macro-
phages, which released IL-10 (Kang
et al., 1994). The development of tole-
rance versus suppressed CHS appears
to correlate with the timing of antigen
application after UVR exposure. Appli-
cation immediately after UVR exposure
resulted in inhibition of CHS but failed
to induce tolerance (Hammerberg
et al., 1994). The latter was only obser-
ved upon antigen application 72 hours
after UVR, when LCs were depleted
and IaþCD11bbright macrophages had
immigrated into the epidermis. CD11b
binds the fragment of the complement
component 3, iC3b, which appears to
be critically involved, as C3-deficient
mice were resistant to UVR-induced
tolerance (Hammerberg et al., 1998).
CONSEQUENCES OF UVR-INDUCED
IMMUNOSUPPRESSION
The characteristic features of UVR-
induced immunosuppression are its
induction by low/physiologic doses,
its antigen specificity, and its influence
primarily on T cell–mediated immune
reactions (Schwarz, 2010). The in vivo
relevance and the biological implica-
tions of UVR-induced immunosuppres-
sion have long been, and partially
remain, unclear. It is at least partially
responsible for the effects of photo-
therapy (Weichenthal and Schwarz,
2005). UVR-induced immunosuppres-
sion certainly is involved in photo-
carcinogenesis. Chronically immunosup-
pressed persons reveal a remarkably
enhanced risk for skin cancer, which
correlates with cumulative UVR
exposure (Euvrard et al., 2003).
In addition, it was assumed that
UVR-induced immunosuppression sup-
ports the exacerbation of skin infec-
tions (Chapman et al., 1995). In fact,
experimental studies demonstrated the
suppression of T-cell reactions against
microbial antigens. However, the clini-
cal experience differs. Except herpes
simplex, the risk for infections, in
particular bacterial infections, after
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UVR exposure is low. Atopic derma-
titis is frequently superinfected with
Staphylococcus aureus, but can be
improved by UVR even without anti-
septic or antibiotic measures. Hence,
the question is obvious: how can an
immunosuppressive regimen such as
UVR improve superinfected dermatoses
without worsening the infection?
The classical adaptive immune
response, which involves antigen-
presenting cells, T cells, and B cells,
is by far less important for cutaneous
antibacterial defense than the evolu-
tionarily much older innate immune
system (Medzhitov and Janeway,
2000). The latter reacts nonspecifi-
cally, but in turn is much faster and
more effective. It involves neutrophils,
NK cells, complement, and also
antimicrobial peptides (AMPs), small
molecules with effective antimicrobial
activity. AMPs are produced in the
skin, in particular b-defensins, psori-
asin, and RNase7 (Harder and
Schro¨der, 2005). It was recently
described that UVR induces AMPs
(Gla¨ser et al., 2009). As UVR disturbs
the epidermal barrier (Jiang et al.,
2006), it appears logical that AMPs
are induced upon UVR exposure as a
counter-regulatory phenomenon, pre-
venting bacterial invasion. As AMPs are
induced by UVR doses in the same
physiologic range as that which sup-
presses the adaptive immune response,
it is fair to speculate that the
downregulation of adaptive immunity
in the skin may be beneficial as well.
The skin is an organ close to
(auto)immunity. One of the best routes
to immunize is via the skin; many auto-
immune diseases affect the skin. The
majority of these reactions are T cell-
driven (Robert and Kupper, 1999). This
gives rise to the hypotheses that T cells
in the skin may not always be beneficial,
but more often harmful. Thus, it is fair to
speculate that a certain level of constant
immunosuppression by daily solar
exposure may prevent the induction of
such adverse immune responses, but this
must be confirmed by future studies.
CONCLUSION
In summary, the view of photo-
immunology has changed over the past
several years (Ullrich and Byrne,
2012). The mechanisms involved are
much more complex than initially
thought. Previously, activation of the
adaptive immune system was always
associated with protection. In turn, sup-
pression was regarded as detrimental.
Nowadays, we assume that a fine-
tuned balance is optimal. Thus, sup-
pression may be as relevant as induc-
tion, and replacing the negatively
perceived term ‘‘suppression’’ with
‘‘regulation’’ may be appropriate. The
essential challenge of regulation is the
toning down of overshooting immune
responses that cause damage. Natural
sun exposure may have a role in
this scenario. Thus, UVR-induced
immunosuppression may be judged
from a different angle. Low/physio-
logic doses of UVR inhibit the adap-
tive immune system but induce parts of
the innate immune system. This may be
beneficial in protecting from microbial
attacks, but it also tones down allergic
and autoimmune reactions. This is in
line with the fact that ambient solar
exposure is crucial and physiologic.
It will be one of the major future
challenges to define the optimal
UVR exposure for each individual, as
excessive exposure is one of the
major environmental threats for
human health; this includes artificial
UVR exposure as well.
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